|
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
RECRUITINGN/ASponsored by Outliers, Inc.
Actively Recruiting
PhaseN/A
SponsorOutliers, Inc.
Started2025-08-12
Est. completion2026-03
Eligibility
Age18 Years – 55 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07380412
Summary
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Eligibility
Age: 18 Years – 55 YearsHealthy volunteers accepted
Inclusion Criteria: * Aged 18-55 years * Currently prescribed stimulant medication for ADHD * Experiencing: sleep difficulty, irritability, anxiety, brain fog * Stable medication dose ≥3 months * Healthy with no uncontrolled chronic conditions * Stable on supplements ≥3 months if applicable * US resident * Willing to maintain current habits Exclusion Criteria: * Chronic conditions (e.g. cancer, mental illness) * Use of psychiatric medications besides stimulants * Pregnancy, breastfeeding, thyroid, liver, kidney conditions * Recent smokers or heavy alcohol use * Night shift workers * Participation in other clinical trials * Allergies to product ingredients
Conditions4
ADHDAnxietyBrain FogSleep Disturbance
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorOutliers, Inc.
Started2025-08-12
Est. completion2026-03
Eligibility
Age18 Years – 55 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07380412